NDC 63323-651 Adenosine

Injection, Solution Intravenous - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
63323-651
Proprietary Name:
Adenosine
Non-Proprietary Name: [1]
Adenosine
Substance Name: [2]
Adenosine
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route(s): [4]
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
  • Labeler Name: [5]
    Fresenius Kabi Usa, Llc
    Labeler Code:
    63323
    FDA Application Number: [6]
    ANDA077897
    Marketing Category: [8]
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date: [9]
    11-27-2017
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Navigator:

    Product Packages

    NDC Code 63323-651-02

    Package Description: 10 VIAL, SINGLE-USE in 1 TRAY / 2 mL in 1 VIAL, SINGLE-USE (63323-651-00)

    NDC Code 63323-651-04

    Package Description: 10 VIAL, SINGLE-USE in 1 TRAY / 4 mL in 1 VIAL, SINGLE-USE (63323-651-01)

    NDC Code 63323-651-20

    Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE

    NDC Code 63323-651-30

    Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON / 30 mL in 1 VIAL, SINGLE-DOSE

    NDC Code 63323-651-89

    Package Description: 10 SYRINGE, PLASTIC in 1 CARTON / 2 mL in 1 SYRINGE, PLASTIC (63323-651-21)

    NDC Code 63323-651-90

    Package Description: 10 SYRINGE, PLASTIC in 1 CARTON / 4 mL in 1 SYRINGE, PLASTIC (63323-651-23)

    Product Details

    What is NDC 63323-651?

    The NDC code 63323-651 is assigned by the FDA to the product Adenosine which is a human prescription drug product labeled by Fresenius Kabi Usa, Llc. The product's dosage form is injection, solution and is administered via intravenous form. The product is distributed in 6 packages with assigned NDC codes 63323-651-02 10 vial, single-use in 1 tray / 2 ml in 1 vial, single-use (63323-651-00), 63323-651-04 10 vial, single-use in 1 tray / 4 ml in 1 vial, single-use (63323-651-01), 63323-651-20 1 vial, single-dose in 1 carton / 20 ml in 1 vial, single-dose, 63323-651-30 1 vial, single-dose in 1 carton / 30 ml in 1 vial, single-dose, 63323-651-89 10 syringe, plastic in 1 carton / 2 ml in 1 syringe, plastic (63323-651-21), 63323-651-90 10 syringe, plastic in 1 carton / 4 ml in 1 syringe, plastic (63323-651-23). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Adenosine?

    Intravenous adenosine injection is indicated for the following:Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome).  When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine injection administration.It is important to be sure the adenosine injection solution actually reaches the systemic circulation (see DOSAGE AND ADMINISTRATION). Adenosine injection does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm.  In the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine injection administration.

    What are Adenosine Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
    • ADENOSINE 3 mg/mL - A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
    • ADENOSINE 3 mg/mL - A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
    • ADENOSINE 3 mg/mL - A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.

    Which are Adenosine UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Adenosine Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Adenosine?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

    Which are the Pharmacologic Classes for Adenosine?

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".